Products

What will AGI do for Amrinone or inamrinone?

This classification denotes a vasodilating agent and phosphodiesterase inhibitor with the molecular formula C10H9N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JUT23379TN, chemically known as 5-amino-(3,4-bipyridin)-6(1h)-one but generally known as amrinone, which bears US NIH Compound Identifier 3698. European Medicines Agency schedules Amrinone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05493MIG. The term AMRINONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules amrinone in its Anatomical Therapeutic Chemical (ATC) Classification. AMRINONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Amrinone or inamrinone bears US NLM identifiers UMLS ID C0002697 and NCI Concept Code C61789. SMILES: C1=CN=CC=C1C2=CNC(=O)C(=C2)N.

How AGI delivers it

Four ways AGI delivers for Amrinone or inamrinone

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Amrinone or inamrinone, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Amrinone or inamrinone, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Amrinone or inamrinone connects

measured by

  • Active Ingredient Potencymodel
  • Assay Contentmodel
  • Compound Puritymodel
  • Particle Size Distributionmodel
  • Related Substance Impurity Levelmodel
  • Residual Solventmodel